BIONET Corp. (TPEX:1784)
Taiwan
· Delayed Price · Currency is TWD 85.40
-0.10 (-0.12%)
Apr 2, 2025, 1:30 PM CST
BIONET Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,222 | 1,127 | 980.38 | 921.42 | 806.58 | Upgrade
|
| Revenue Growth (YoY) | 8.40% | 14.99% | 6.40% | 14.24% | 4.00% | Upgrade
|
| Cost of Revenue | 536.26 | 489.03 | 438.16 | 418.35 | 394.62 | Upgrade
|
| Gross Profit | 685.77 | 638.28 | 542.22 | 503.07 | 411.96 | Upgrade
|
| Selling, General & Admin | 483.75 | 433.23 | 391.95 | 385.97 | 362.51 | Upgrade
|
| Research & Development | 139.02 | 118.75 | 90.3 | 85.57 | 52.45 | Upgrade
|
| Operating Expenses | 623.37 | 553.58 | 485.39 | 471.86 | 415.77 | Upgrade
|
| Operating Income | 62.4 | 84.69 | 56.83 | 31.21 | -3.81 | Upgrade
|
| Interest Expense | -1.28 | -0.41 | -0.46 | -0.39 | -0.33 | Upgrade
|
| Interest & Investment Income | 24.91 | 15.03 | 8.96 | 7.37 | 8.51 | Upgrade
|
| Currency Exchange Gain (Loss) | 6.18 | -0.42 | 6.29 | -2.6 | -0.69 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.31 | 5.56 | 4.18 | 5.41 | 6.79 | Upgrade
|
| EBT Excluding Unusual Items | 99.52 | 104.46 | 75.8 | 41.01 | 10.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.33 | 2.63 | -5.35 | 0.21 | -4.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.39 | 0 | 0.01 | -0.03 | -0.04 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.16 | Upgrade
|
| Pretax Income | 102.24 | 107.08 | 70.46 | 41.19 | 6.42 | Upgrade
|
| Income Tax Expense | 32.38 | 25.69 | 16.87 | 8.55 | 5.18 | Upgrade
|
| Earnings From Continuing Operations | 69.87 | 81.4 | 53.59 | 32.64 | 1.25 | Upgrade
|
| Minority Interest in Earnings | 13.84 | -3 | -15.62 | -6.02 | 11.5 | Upgrade
|
| Net Income | 83.7 | 78.4 | 37.97 | 26.62 | 12.74 | Upgrade
|
| Net Income to Common | 83.7 | 78.4 | 37.97 | 26.62 | 12.74 | Upgrade
|
| Net Income Growth | 6.76% | 106.47% | 42.62% | 108.96% | 87.28% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 50 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | 0.33% | -0.16% | -0.53% | 0.14% | -0.07% | Upgrade
|
| EPS (Basic) | 1.65 | 1.55 | 0.75 | 0.52 | 0.25 | Upgrade
|
| EPS (Diluted) | 1.65 | 1.55 | 0.75 | 0.52 | 0.25 | Upgrade
|
| EPS Growth | 6.45% | 107.50% | 42.86% | 108.83% | 91.58% | Upgrade
|
| Free Cash Flow | 75.15 | 133.05 | 65.78 | 3.71 | 46.83 | Upgrade
|
| Free Cash Flow Per Share | 1.48 | 2.63 | 1.30 | 0.07 | 0.92 | Upgrade
|
| Dividend Per Share | 1.410 | 0.663 | 0.654 | 0.448 | 0.168 | Upgrade
|
| Dividend Growth | 112.67% | 1.44% | 45.83% | 166.63% | 38.47% | Upgrade
|
| Gross Margin | 56.12% | 56.62% | 55.31% | 54.60% | 51.08% | Upgrade
|
| Operating Margin | 5.11% | 7.51% | 5.80% | 3.39% | -0.47% | Upgrade
|
| Profit Margin | 6.85% | 6.96% | 3.87% | 2.89% | 1.58% | Upgrade
|
| Free Cash Flow Margin | 6.15% | 11.80% | 6.71% | 0.40% | 5.81% | Upgrade
|
| EBITDA | 89.71 | 109.06 | 83.41 | 55.17 | 23.41 | Upgrade
|
| EBITDA Margin | 7.34% | 9.68% | 8.51% | 5.99% | 2.90% | Upgrade
|
| D&A For EBITDA | 27.31 | 24.37 | 26.59 | 23.96 | 27.21 | Upgrade
|
| EBIT | 62.4 | 84.69 | 56.83 | 31.21 | -3.81 | Upgrade
|
| EBIT Margin | 5.11% | 7.51% | 5.80% | 3.39% | -0.47% | Upgrade
|
| Effective Tax Rate | 31.67% | 23.99% | 23.94% | 20.75% | 80.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.